Efficacy of seventh generation bonding agents as desensitizers in patients with dentin hypersensitivity: a randomized clinical trial.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
14 May 2024
Historique:
received: 14 11 2023
accepted: 09 05 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: epublish

Résumé

Dentin hypersensitivity (DH) is one of the most challenging and persistent dental complaints characterized by transient, intense pain triggered by various stimuli. It affects a significant portion of the global population, predominantly those aged 20-40. This study aims to evaluate the desensitizing efficacy of seventh-generation dentin bonding agents (Single Bond Universal by 3 M ESPE and Xeno-V + by Dentsply) against a control group using Bifluorid 12 by Voco in mitigating DH within a month of the follow-up period. This was a single-center, parallel-group, double-blind, controlled randomized clinical trial conducted at Dow University of Health Sciences, Karachi, Pakistan. A total of 105 patients with DH were allocated into three groups for this study. The patients were divided into three groups (Single Bond Universal by 3 M ESPE and Xeno-V + by Dentsply) and the control group containing fluoride varnish (Bifluorid 12 by Voco). Discomfort Interval Scale scores and Schiff Cold Air Sensitivity Scale scores were recorded at baseline, immediately after the intervention, after 01 weeks, and after 01 month. All the materials demonstrated a statistically significant reduction in discomfort and sensitivity (DIS scores p-value 0.01) immediately after 01 week and over a period of 01 month after treatment compared with the baseline scores before application, with no single material proving superior over the one-month observation period. The study also provided insights into dental hygiene practices, with a significant majority using a toothbrush and sensitivity patterns, with cold stimuli being the most common cause of sensitivity. The study demonstrates that Single Bond Universal, Xeno V+, and Bifluorid 12 are equally effective in reducing dentin hypersensitivity, with no distinct superiority observed over a one-month period. The findings highlight the potential of fluoride varnishes as a less technique-sensitive and cost-effective option for treating DH, offering valuable insights for future research and clinical practice. NCT04225247 ( https://clinicaltrials.gov/study/NCT04225247 ), Date of Registration: 13/01/2020. (Retrospectively registered).

Sections du résumé

BACKGROUND BACKGROUND
Dentin hypersensitivity (DH) is one of the most challenging and persistent dental complaints characterized by transient, intense pain triggered by various stimuli. It affects a significant portion of the global population, predominantly those aged 20-40. This study aims to evaluate the desensitizing efficacy of seventh-generation dentin bonding agents (Single Bond Universal by 3 M ESPE and Xeno-V + by Dentsply) against a control group using Bifluorid 12 by Voco in mitigating DH within a month of the follow-up period.
METHODS METHODS
This was a single-center, parallel-group, double-blind, controlled randomized clinical trial conducted at Dow University of Health Sciences, Karachi, Pakistan. A total of 105 patients with DH were allocated into three groups for this study. The patients were divided into three groups (Single Bond Universal by 3 M ESPE and Xeno-V + by Dentsply) and the control group containing fluoride varnish (Bifluorid 12 by Voco). Discomfort Interval Scale scores and Schiff Cold Air Sensitivity Scale scores were recorded at baseline, immediately after the intervention, after 01 weeks, and after 01 month.
RESULTS RESULTS
All the materials demonstrated a statistically significant reduction in discomfort and sensitivity (DIS scores p-value 0.01) immediately after 01 week and over a period of 01 month after treatment compared with the baseline scores before application, with no single material proving superior over the one-month observation period. The study also provided insights into dental hygiene practices, with a significant majority using a toothbrush and sensitivity patterns, with cold stimuli being the most common cause of sensitivity.
CONCLUSION CONCLUSIONS
The study demonstrates that Single Bond Universal, Xeno V+, and Bifluorid 12 are equally effective in reducing dentin hypersensitivity, with no distinct superiority observed over a one-month period. The findings highlight the potential of fluoride varnishes as a less technique-sensitive and cost-effective option for treating DH, offering valuable insights for future research and clinical practice.
TRIAL REGISTRATION BACKGROUND
NCT04225247 ( https://clinicaltrials.gov/study/NCT04225247 ), Date of Registration: 13/01/2020. (Retrospectively registered).

Identifiants

pubmed: 38745306
doi: 10.1186/s12903-024-04352-0
pii: 10.1186/s12903-024-04352-0
doi:

Banques de données

ClinicalTrials.gov
['NCT04225247']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

562

Informations de copyright

© 2024. The Author(s).

Références

West NX, et al. Prevalence of dentine hypersensitivity and study of associated factors: a European population-based cross-sectional study. J Dent. 2013;41(10):841–51.
doi: 10.1016/j.jdent.2013.07.017 pubmed: 23911597
Kar PP, et al. Comparison of the effectiveness of three different desensitizing toothpastes in reducing dentin hypersensitivity: a 4-week clinical study. J Conservative Dentistry: JCD. 2019;22(2):181.
doi: 10.4103/JCD.JCD_304_18 pubmed: 31142990 pmcid: 6519181
Cox CF et al. Biological basis for clinical success: pulp protection and the tooth-restoration interface. Pract Periodontics Aesthet Dent, 1999. 11(7): p. 819 – 26; quiz 827.
Borges R, et al. How are bioactive ceramics shaping the future of dentin hypersensitivity management through glass ionomer cements and laser therapy? Mater Lett. 2024;354:135366.
doi: 10.1016/j.matlet.2023.135366
Arshad S, Zaidi SJA, Farooqui WA. Comparative efficacy of BioMin-F, Colgate Sensitive Pro-relief and Sensodyne Rapid Action in relieving dentin hypersensitivity: a randomized controlled trial. BMC Oral Health. 2021;21:1–12.
doi: 10.1186/s12903-021-01864-x
Orchardson R, Gillam DG. Managing dentin hypersensitivity. J Am Dent Association. 2006;137(7):990–8.
doi: 10.14219/jada.archive.2006.0321
Clark GE, Troullos ES. Designing hypersensitivity clinical studies. Dental Clin N Am. 1990;34(3):531–44.
doi: 10.1016/S0011-8532(22)01133-8
Grover V, et al. ISP good clinical practice recommendations for the management of dentin hypersensitivity. J Indian Soc Periodontology. 2022;26(4):307.
doi: 10.4103/jisp.jisp_233_22
Erdemir U, et al. The efficacy of three desensitizing agents used to treat dentin hypersensitivity. J Am Dent Association. 2010;141(3):285–96.
doi: 10.14219/jada.archive.2010.0162
Gillam D, Koyi B. Dentin hypersensitivity in clinical practice. JP Medical Ltd.; 2020.
Hypersensitivity CABoD. Consensus-based recommendations for the diagnosis and management of dentin hypersensitivity. J Can Dent Assoc. 2003;69(4):221–6.
de Oliveira RP, et al. Effect of desensitizing agents on dentin hypersensitivity after non-surgical periodontal therapy: a systematic review and meta-analysis. J Dent. 2020;103:103498.
doi: 10.1016/j.jdent.2020.103498 pubmed: 33069772
Tyas MJ, Burrow MF. Adhesive restorative materials: a review. Aust Dent J, 2004. 49(3): p. 112 – 21; quiz 154.
Heaton LJ, Barlow AP, Coldwell SE. Development of labeled magnitude scales for the assessment of pain of dentin hypersensitivity. J Orofac Pain. 2013;27(1):72.
doi: 10.11607/jop.954 pubmed: 23424722 pmcid: 3610536
Rocha MOC, et al. Sensitivity and specificity of assessment scales of dentin hypersensitivity–an accuracy study. Brazilian oral Res. 2020;34:e043.
doi: 10.1590/1807-3107bor-2020.vol34.0043
Polderman R, Frencken J. Comparison between effectiveness of a low-viscosity glass ionomer and a resin-based glutaraldehyde containing primer in treating dentine hypersensitivity—a 25.2-month evaluation. J Dent. 2007;35(2):144–9.
doi: 10.1016/j.jdent.2006.06.005 pubmed: 16973252
Schiff T, et al. Efficacy of a dentifrice containing potassium nitrate, soluble pyrophosphate, PVM/MA copolymer, and sodium fluoride on dentinal hypersensitivity: a twelve-week clinical study. J Clin Dent. 1994;5:87–92.
pubmed: 8534380
Mohd-Dom TN, et al. Oral health literacy and behavior of health sciences university students. J Dentistry Indonesia. 2015;22(2):56–62.
doi: 10.14693/jdi.v22i2.404
Riad A, et al. Czech and Slovak dental students’ oral health-related knowledge, attitudes, and behaviours (KAB): multi-country cross-sectional study. Int J Environ Res Public Health. 2022;19(5):2717.
doi: 10.3390/ijerph19052717 pubmed: 35270410 pmcid: 8910048
Akber A et al. Frequency of dentine hypersensitivity: a cross-sectional study. Pakistan Oral Dent J, 2016. 36(3).
Graf H, Galasse R. Morbidity, prevalence and intraoral distribution of hypersensitive teeth. J Dent Res. 1977;56(2):162.
Arthanari A et al. Etiology and management of hypersensitivity of Teeth-A Review. J Pharm Res Int, 2021: p. 317–29.
Vijaya V, et al. Association of dentine hypersensitivity with different risk factors–A cross sectional study. J Int oral Health: JIOH. 2013;5(6):88.
pubmed: 24453451 pmcid: 3895724
Amarasena N, et al. Dentine hypersensitivity in a private practice patient population in Australia. J Rehabil. 2011;38(1):52–60.
doi: 10.1111/j.1365-2842.2010.02132.x
Bahşi E, et al. An analysis of the aetiology, prevalence and clinical features of dentine hypersensitivity in a general dental population. Volume 16. European Review for Medical & Pharmacological Sciences; 2012. 8.
Rees J, et al. The prevalence of dentine hypersensitivity in a hospital clinic population in Hong Kong. J Dent. 2003;31(7):453–61.
doi: 10.1016/S0300-5712(03)00092-7 pubmed: 12927456
Ye W, Feng XP, Li R. The prevalence of dentine hypersensitivity in Chinese adults. J Rehabil. 2012;39(3):182–7.
doi: 10.1111/j.1365-2842.2011.02248.x
Cunha-Cruz J, et al. The prevalence of dentin hypersensitivity in general dental practices in the northwest United States. J Am Dent Assoc. 2013;144(3):288–96.
doi: 10.14219/jada.archive.2013.0116 pubmed: 23449905 pmcid: 3819160
Chabanski M, et al. Clinical evaluation of cervical dentine sensitivity in a population of patients referred to a specialist periodontology department: a pilot study. J Rehabil. 1997;24(9):666–72.
doi: 10.1111/j.1365-2842.1997.tb01079.x
Rane P, et al. Epidemiological study to evaluate the prevalence of dentine hypersensitivity among patients. J Int oral Health: JIOH. 2013;5(5):15.
pubmed: 24324299 pmcid: 3845279
Al-Otaibi M. The miswak (chewing stick) and oral health. Studies on oral hygiene practices of urban Saudi arabians. Swed Dent J Suppl, 2004(167): p. 2–75.
Wainwright J, Sheiham A. An analysis of methods of toothbrushing recommended by dental associations, toothpaste and toothbrush companies and in dental texts. Br Dent J. 2014;217(3):E5–5.
doi: 10.1038/sj.bdj.2014.651 pubmed: 25104719
Folayan MO, et al. Association between early childhood caries and poverty in low and middle income countries. BMC Oral Health. 2020;20:1–8.
doi: 10.1186/s12903-019-0991-2
Addy M. Dentine hypersensitivity: new perspectives on an old problem. Int Dent J. 2002;52(S5P2):367–75.
doi: 10.1002/j.1875-595X.2002.tb00936.x
Dhaliwal JS, et al. Prevalence of dentine hypersensitivity: a cross-sectional study in rural Punjabi indians. J Indian Soc Periodontology. 2012;16(3):426.
doi: 10.4103/0972-124X.100924
Rees J, Addy M. A cross-sectional study of buccal cervical sensitivity in UK general dental practice and a summary review of prevalence studies. Int J Dental Hygiene. 2004;2(2):64–9.
doi: 10.1111/j.1601-5029.2004.00068.x
Ritter AV, et al. Treating cervical dentin hypersensitivity with fluoride varnish. J Am Dent Association. 2006;137(7):1013–20.
doi: 10.14219/jada.archive.2006.0324
Torres CRG, et al. The effect of three desensitizing agents on dentin hypersensitivity: a randomized, split-mouth clinical trial. Oper Dent. 2014;39(5):E186–94.
doi: 10.2341/13-057 pubmed: 24720265
Yu X, et al. Comparative in vivo study on the desensitizing efficacy of dentin desensitizers and one-bottle self-etching adhesives. Oper Dent. 2010;35(3):279–86.
doi: 10.2341/09-346-C pubmed: 20533627
Anderson CJ, Kugel G, Gerlach R. A randomized, controlled comparison of two professional dentin desensitizing agents immediately post-treatment and 2 months post-treatment. Am J Dent. 2018;31(6):297–302.
pubmed: 30658375
Nardi G, et al. Effectiveness of two different desensitizing varnishes in reducing tooth sensitivity: a randomized double-blind clinical trial. Volume 9. Oral & Implantology; 2016. p. 185. 4.
van Loveren C, et al. Dentin hypersensitivity management. Clin Dentistry Reviewed. 2018;2:1–10.
Ferrari M, et al. Clinical evaluation of a one-bottle bonding system for desensitizing exposed roots. Am J Dent. 1999;12(5):243–9.
pubmed: 10649916
Pandurić V, et al. The efficiency of dentine adhesives in treating non-caries cervical lesions. J Rehabil. 2001;28(12):1168–74.
doi: 10.1046/j.1365-2842.2001.00779.x
Kakaboura A, et al. Clinical effectiveness of two agents on the treatment of tooth cervical hypersensitivity. Am J Dent. 2005;18(4):291–5.
pubmed: 16296439
Patil SA, Naik BD, Suma R. Evaluation of three different agents for in-office treatment of dentinal hypersensitivity: a controlled clinical study. Indian J Dent Res. 2015;26(1):38.
doi: 10.4103/0970-9290.156796 pubmed: 25961613
Hajizadeh H, et al. Comparing the effect of a desensitizing material and a self-etch adhesive on dentin sensitivity after periodontal surgery: a randomized clinical trial. Volume 42. Restorative Dentistry & Endodontics; 2017. p. 168. 3.
Marto CM, et al. Evaluation of the efficacy of dentin hypersensitivity treatments—A systematic review and follow-up analysis. J Rehabil. 2019;46(10):952–90.
doi: 10.1111/joor.12842

Auteurs

Sumaiya Shabbir (S)

Department of Periodontology, Dow International Dental College, Dow University of Health Sciences, Karachi, Pakistan.

Shahbaz Ahmed (S)

Department of Operative Dentistry, Dr Ishrat-ul-Ebad Khan Institute of Oral Health Sciences, Dow University of Health Sciences, Karachi, Pakistan.

Syed Jaffar Abbas Zaidi (SJA)

Department of Oral Biology, Dow Dental College, Dow University of Health Sciences, Karachi Sindh, 74200, Pakistan. jaffar.zaidi@duhs.edu.pk.

Sania Riaz (S)

Department of Periodontology, Baqai Dental College, Baqai Medical University, Karachi, Pakistan.

Huma Sarwar (H)

Department of Operative Dentistry, Dr Ishrat-ul-Ebad Khan Institute of Oral Health Sciences, Dow University of Health Sciences, Karachi, Pakistan.

Muhammad Taqi (M)

Department of Community Dentistry, Dow Dental College, Dow University of Health Sciences, Karachi, Pakistan.

Zia Ur Rahman Khan (ZU)

Department of Oral Medicine, Baqai Dental College, Baqai Medical University, Karachi, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH